We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
-8.2%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$462M
AUM Growth
-$51.6M
Cap. Flow
-$441K
Cap. Flow %
-0.1%
Top 10 Hldgs %
15.6%
Holding
395
New
18
Increased
8
Reduced
14
Closed
13

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$2.31M
2
ABBV icon
AbbVie
ABBV
+$1.95M
3
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$1.27M
4
GERN icon
Geron
GERN
+$1.18M
5
KHC icon
Kraft Heinz
KHC
+$1.16M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.93M
2
AMAG
AMAG Pharmaceuticals
AMAG
+$1.86M
3
AEC
ASSOCIATED ESTATES REALTY CORP
AEC
+$1.72M
4
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
+$1.3M
5
PLL
PALL CORP
PLL
+$1.25M

Sector Composition

Rank Sector Weight
1 Technology 16.61%
2 Financials 14.94%
3 Healthcare 14.92%
4 Industrials 11.55%
5 Consumer Staples 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNSL
226
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$674K 0.15%
35,000
– –
SIOX
227
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$659K 0.14%
+6,375
New +$748K
AEGN
228
DELISTED
Aegion Corp
AEGN
$659K 0.14%
40,000
– –
BAX icon
229
Baxter International
BAX
$13.5B
$657K 0.14%
20,000
-16,820
-46% -$637K
HTGC icon
230
Hercules Capital
HTGC
$3.07B
$657K 0.14%
65,000
– –
BSX icon
231
Boston Scientific
BSX
$69.5B
$656K 0.14%
40,000
– –
COL
232
DELISTED
Rockwell Collins
COL
$655K 0.14%
8,000
– –
CATM
233
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$654K 0.14%
20,000
– –
HRB icon
234
H&R Block
HRB
$5.58B
$652K 0.14%
18,000
– –
APD icon
235
Air Products & Chemicals
APD
$65.7B
$638K 0.14%
5,405
– –
FLR icon
236
Fluor
FLR
$7.01B
$635K 0.14%
15,000
– –
COF icon
237
Capital One
COF
$128B
$633K 0.14%
8,733
– –
DVN icon
238
Devon Energy
DVN
$52.1B
$631K 0.14%
17,000
– –
RIGL icon
239
Rigel Pharmaceuticals
RIGL
$681M
$630K 0.14%
+25,500
New +$761K
BXLT
240
DELISTED
BAXALTA INC COM STK (DE)
BXLT
$630K 0.14%
+20,000
New +$690K
CUB
241
DELISTED
Cubic Corporation
CUB
$629K 0.14%
15,000
– –
ORIT
242
DELISTED
Oritani Financial Corp. New
ORIT
$625K 0.14%
40,000
– –
ADM icon
243
Archer Daniels Midland
ADM
$38.2B
$622K 0.13%
15,000
– –
FTI icon
244
TechnipFMC
FTI
$28.1B
$620K 0.13%
26,880
– –
RSG icon
245
Republic Services
RSG
$64.8B
$618K 0.13%
15,000
– –
EBAY icon
246
eBay
EBAY
$50.6B
$611K 0.13%
25,000
-34,400
-58% -$925K
KIM icon
247
Kimco Realty
KIM
$17.2B
$611K 0.13%
25,000
– –
TMO icon
248
Thermo Fisher Scientific
TMO
$213B
$611K 0.13%
5,000
– –
KSS icon
249
Kohl's
KSS
$2.17B
$602K 0.13%
13,000
– –
VTRS icon
250
Viatris
VTRS
$20.4B
$594K 0.13%
14,750
– –
8 9
10
11 12

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q3 2015 Portfolio in Review

As of Q3 2015, NJ State Employees Deferred Compensation Plan held 395 positions worth $462M, down 10% from $514M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

NJ State Employees Deferred Compensation Plan's Q3 2015 filing shows 18 new, 8 increased, 14 reduced and 13 closed positions. Its largest new stake was Biogen: 7,000 shares worth $2.04M. The largest sale was Johnson & Johnson, an estimated $1.93M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • NJ State Employees Deferred Compensation Plan's largest Q3 2015 buy was Biogen: 7,000 shares worth $2.04M.
  • NJ State Employees Deferred Compensation Plan added most to AbbVie in Q3 2015, an estimated $1.95M increase.
  • NJ State Employees Deferred Compensation Plan's biggest Q3 2015 reduction was Johnson & Johnson, cutting an estimated $1.93M.
  • NJ State Employees Deferred Compensation Plan fully exited ASSOCIATED ESTATES REALTY CORP in Q3 2015, selling an estimated $1.72M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 16% of its $462M portfolio in Q3 2015.
  • NJ State Employees Deferred Compensation Plan opened 18 new positions and closed 13 in Q3 2015.
  • NJ State Employees Deferred Compensation Plan's portfolio value fell 10% quarter-over-quarter to $462M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q3 2015, filed 2 Nov 2015.